To analyze the impact of EGFR mutations on the tumor immune microenvironment (TIME) in lung adenocarcinoma (LUAD) using machine learning and single-cell transcriptomics.
Key Findings:
EGFR-mutant tumors showed enrichment of immunosuppressive cells like TIGIT+ regulatory T cells, neutrophils, and macrophages.
Wild-type tumors had higher levels of immune-active cells, including ZNF683+CD8+ tissue-resident memory T cells and FGFBP2+CD16high natural killer cells.
Five distinct TIME subtypes were identified, with EGFR-mutant profiles correlating with poor prognosis.
Interpretation:
The study reveals significant differences in the immune microenvironment between EGFR-mutant and wild-type LUAD, suggesting that EGFR mutations influence immune cell composition and may affect responses to immunotherapy.
Limitations:
The study's findings are based on a specific cohort and may not be universally applicable.
Further validation in larger, diverse populations is needed to confirm the results.
Conclusion:
Machine learning-based analysis of single-cell transcriptomics provides insights into the immune landscape of EGFR-mutant LUAD, highlighting the potential for personalized immunotherapy approaches.
